Atea Pharmaceuticals, Inc. (AVIR)
5.45
-0.06
(-1.09%)
USD |
NASDAQ |
Aug 27, 16:00
5.42
-0.03
(-0.55%)
After-Hours: 20:00
Atea Pharmaceuticals Shareholders Equity (Quarterly) : 204.16M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 204.16M |
| March 31, 2026 | 233.71M |
| December 31, 2025 | 275.43M |
| September 30, 2025 | 315.78M |
| June 30, 2025 | 364.42M |
| March 31, 2025 | 411.08M |
| December 31, 2024 | 438.87M |
| September 30, 2024 | 458.52M |
| June 30, 2024 | 476.47M |
| March 31, 2024 | 504.37M |
| December 31, 2023 | 555.19M |
| September 30, 2023 | 581.73M |
| June 30, 2023 | 602.35M |
| March 31, 2023 | 618.18M |
| Date | Value |
|---|---|
| December 31, 2022 | 640.57M |
| September 30, 2022 | 663.19M |
| June 30, 2022 | 660.46M |
| March 31, 2022 | 679.88M |
| December 31, 2021 | 710.08M |
| September 30, 2021 | 581.45M |
| June 30, 2021 | 597.86M |
| March 31, 2021 | 586.26M |
| December 31, 2020 | 547.80M |
| September 30, 2020 | 99.23M |
| June 30, 2020 | 112.62M |
| March 31, 2020 | 15.74M |
| December 31, 2019 | 19.54M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 63.61M |
| CorMedix, Inc. | 460.83M |
| Eloxx Pharmaceuticals, Inc. | 46.42M |
| Cannabis Global, Inc. | -4.772M |
| Breakthrough Chemistry, Inc. | 0.8373M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 232.28M |
| Total Liabilities (Quarterly) | 28.12M |
| Debt to Equity Ratio | 0.0021 |
| Current Ratio | 8.131 |
| Net Debt Paydown Yield | 0.05% |